Aberdeen India Fund, Inc. (IFN) vs Medibank Private Limited (MPL.AX)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| IFN | MPL.AX | |
|---|---|---|
| Sector | Financial Services | Financial Services |
| Industry | Asset Management | Insurance - Specialty |
| Size band | SMALL | MID |
| Listing | NYSE | ASX |
| Country | Singapore | Australia |
| Theme | asset-management | health-insurance |
| Price and returns | ||
| Last close | $10.27 | 5.05 AUD |
| Return · 1 week | −2.47% | +5.65% |
| Return · 1 month | −3.57% | +10.99% |
| Return · 3 months | −11.69% | −3.63% |
| Return · year to date | −21.79% | +6.99% |
| Return · 1 year | −26.20% | +7.44% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −33.61% | −4.90% |
| 52-week high | $15.47 | 5.31 AUD |
| 52-week low | $10.13 | 4.06 AUD |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $443.92M | $9.76B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $1.42M | $30.90M |
| Employees | — | 5,001 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | 19.87× |
| Price to earnings · forward | n/a (negative forward earnings) | 17.02× |
| Price to sales | 91.47× | 1.35× |
| Price to book | 0.81× | 5.18× |
| Enterprise value to EBITDA | — | 9.52× |
| Enterprise value to revenue | 91.02× | 1.00× |
| Earnings per share · trailing | -2.40 | 0.23 |
| Profitability | ||
| Operating margin | −45.27% | 10.72% |
| Profit margin | −2038.95% | 6.87% |
| Return on equity | −15.90% | 27.23% |
| Return on assets | −0.34% | 12.65% |
| Growth | ||
| Revenue growth | −12.40% | +12.60% |
| Earnings growth | — | +109.90% |
| Balance sheet and payout | ||
| Debt / equity (%) | — | 11.36 |
| Current ratio | 5.37 | 1.96 |
| Dividend yield | 20.64% | 4.22% |
| Payout ratio | 59.47% | 79.74% |
| Trend and volatility | ||
| RSI · 14 | 35.48 | 75.65 |
| ADX · 14 | 42.91 | 30.50 |
| 50-day average | $10.98 | 4.69 AUD |
| 200-day average | $11.85 | 4.71 AUD |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 1.80% | 1.82% |
The full IFN analysis
Everything this table leaves out for Aberdeen India Fund, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the IFN argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full IFN analysisThe full MPL.AX analysis
Everything this table leaves out for Medibank Private Limited: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the MPL.AX argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full MPL.AX analysis